Heart failure with preserved ejection fraction: insights from recent clinical researches
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Mi-Na | - |
dc.contributor.author | Park, Seong-Mi | - |
dc.date.accessioned | 2021-08-31T01:47:01Z | - |
dc.date.available | 2021-08-31T01:47:01Z | - |
dc.date.created | 2021-06-18 | - |
dc.date.issued | 2020-05 | - |
dc.identifier.issn | 1226-3303 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/56246 | - |
dc.description.abstract | Heart failure (HF) with preserved ejection fraction (HFpEF) accounts for nearly half of the cases of HF and its incidence might be increasing with the aging society. Patients with HFpEF present with significant symptoms, including exercise intolerance, impaired quality of life, and have a poor prognosis as well as frequent hospitalization and increased mortality compared with HF with reduced ejection fraction. The concept of HFpEF is still evolving and may be a virtual complex rather than a real systemic disorder. Thus, beyond solely targeting cardiac abnormalities management strategies need to be extended, such as left ventricular diastolic dysfunction. In this review, we examine new diagnostic algorithms, pathophysiology, current management status, and ongoing trials based on heterogeneous pathophysiology and etiology in HFpEF. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | KOREAN ASSOC INTERNAL MEDICINE | - |
dc.subject | ANGIOTENSIN-ALDOSTERONE SYSTEM | - |
dc.subject | PATIENTS GREATER-THAN-OR-EQUAL-TO-65 YEARS | - |
dc.subject | CORONARY MICROVASCULAR DYSFUNCTION | - |
dc.subject | REDUCE LAP-HF | - |
dc.subject | SYSTOLIC FUNCTION | - |
dc.subject | OLDER PATIENTS | - |
dc.subject | BETA-BLOCKERS | - |
dc.subject | BLOOD-PRESSURE | - |
dc.subject | VENTRICULAR-FUNCTION | - |
dc.subject | EXERCISE CAPACITY | - |
dc.title | Heart failure with preserved ejection fraction: insights from recent clinical researches | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Kim, Mi-Na | - |
dc.contributor.affiliatedAuthor | Park, Seong-Mi | - |
dc.identifier.doi | 10.3904/kjim.2020.104 | - |
dc.identifier.scopusid | 2-s2.0-85084567071 | - |
dc.identifier.wosid | 000530244800003 | - |
dc.identifier.bibliographicCitation | KOREAN JOURNAL OF INTERNAL MEDICINE, v.35, no.3, pp.514 - 534 | - |
dc.relation.isPartOf | KOREAN JOURNAL OF INTERNAL MEDICINE | - |
dc.citation.title | KOREAN JOURNAL OF INTERNAL MEDICINE | - |
dc.citation.volume | 35 | - |
dc.citation.number | 3 | - |
dc.citation.startPage | 514 | - |
dc.citation.endPage | 534 | - |
dc.type.rims | ART | - |
dc.type.docType | Review | - |
dc.identifier.kciid | ART002580128 | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | General & Internal Medicine | - |
dc.relation.journalWebOfScienceCategory | Medicine, General & Internal | - |
dc.subject.keywordPlus | ANGIOTENSIN-ALDOSTERONE SYSTEM | - |
dc.subject.keywordPlus | PATIENTS GREATER-THAN-OR-EQUAL-TO-65 YEARS | - |
dc.subject.keywordPlus | CORONARY MICROVASCULAR DYSFUNCTION | - |
dc.subject.keywordPlus | REDUCE LAP-HF | - |
dc.subject.keywordPlus | SYSTOLIC FUNCTION | - |
dc.subject.keywordPlus | OLDER PATIENTS | - |
dc.subject.keywordPlus | BETA-BLOCKERS | - |
dc.subject.keywordPlus | BLOOD-PRESSURE | - |
dc.subject.keywordPlus | VENTRICULAR-FUNCTION | - |
dc.subject.keywordPlus | EXERCISE CAPACITY | - |
dc.subject.keywordAuthor | Heart failure | - |
dc.subject.keywordAuthor | Preserved ejection fraction | - |
dc.subject.keywordAuthor | Therapy | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.